Skip to content
Toggle main navigation
Immunize Oregon logo
Immunize Oregon logo
  • Welcome
    • Immunize Oregon
  • Vaxx Clinic
  • Events
  • Groups
  • News
  • Opportunities
  • Lobby
    Log in
    Request to join
    Select an available language
    EN

    News

    All
    3-D printing
    Abdul Latif Jameel Poverty Action Lab (J-PAL)
    Abdul Latif Jameel Water and Food Systems Lab (J-WAFS)
    Administration
    Aeronautical and astronautical engineering
    Africa
    Agriculture
    Algorithms
    Alumni/ae
    Alzheimer's
    Anesthesia
    Anthropology
    Antibiotics
    Artificial intelligence
    Asia
    See all

    Results (14)

    The long history of vaccine hesitancy

    The long history of vaccine hesitancy

    Debates about vaccines are a recurring feature of contemporary politics. It turns out they actually date back more than 200 years, since the development of the first smallpox vaccine. MIT Professor Thomas Levenson, one of the country’s leading science writers, explores this important history in a new book about the contours of anti-vaccination thought. Levenson identifies different types of argume
    June 12, 2026
    A new vaccine adjuvant could make it easier to eradicate polio

    A new vaccine adjuvant could make it easier to eradicate polio

    In the United States, children routinely receive an injectable form of the polio vaccine. This vaccine is very effective at preventing illness, but it doesn’t block transmission of the polio virus as well as the oral polio vaccine does.Poliovirus is usually transmitted through contaminated food or water, so the GI tract is where the body is first exposed. Because the oral vaccine induces a mucosal
    June 3, 2026
    A new approach to cancer vaccination yields more powerful T cells

    A new approach to cancer vaccination yields more powerful T cells

    MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines — an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious diseases.Most vaccines generate both antibodies and T cells that can target the vaccine antigen by activating antigen-presenting cells, such as dendritic cells. In this study, the researchers boosted the
    May 13, 2026
    MIT study finds targets for a new tuberculosis vaccine

    MIT study finds targets for a new tuberculosis vaccine

    A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine for TB, the world’s deadliest infectious disease.In the new study, a team of MIT biological engineers was able to identify a handful of immunogenic peptides, out of more than 4,000 bacterial proteins, that appear to stimulate a strong response from a type of T cells respons
    November 5, 2025
    Five with MIT ties elected to National Academy of Medicine for 2025

    Five with MIT ties elected to National Academy of Medicine for 2025

    On Oct. 20 during its annual meeting, the National Academy of Medicine announced the election of 100 new members, including MIT faculty members Dina Katabi and Facundo Batista, along with three additional MIT alumni.Election to the National Academy of Medicine (NAM) is considered one of the highest honors in the fields of health and medicine, recognizing individuals who have demonstrated outstandi
    October 22, 2025
    MIT researchers develop AI tool to improve flu vaccine strain selection

    MIT researchers develop AI tool to improve flu vaccine strain selection

    Every year, global health experts are faced with a high-stakes decision: Which influenza strains should go into the next seasonal vaccine? The choice must be made months in advance, long before flu season even begins, and it can often feel like a race against the clock. If the selected strains match those that circulate, the vaccine will likely be highly effective. But if the prediction is off, pr
    August 28, 2025
    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    3 Questions: Darrell Irvine on making HIV vaccines more powerful

    An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: a nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles contain saponin, a compound derived from the bark of the Chilean soapbark tree, along with a molecule called MPLA, each of which helps to activate the immune system. The adj
    December 12, 2023
    A snapshot of cancer vaccine development

    A snapshot of cancer vaccine development

    The road to effective cancer vaccines has been long and difficult.  Although initial attempts to use a vaccine to treat cancer date back to the 1910s, the first effective therapeutic vaccine would not emerge until about a century later, when Sipuleucel-T was used to treat prostate cancer in 2010. While the FDA-approved prostate cancer vaccine generated much excitement, its success has proven diffi
    August 15, 2023
    Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact

    Celebrating 20 years of discovery, Picower Institute looks ahead to continuing impact

    If ever there was an event that would seem designed for dwelling on the past, it would be the anniversary celebration of an institute centered on the study of memory, but the first of many insights offered by the 20th Anniversary Exhibition of The Picower Institute for Learning and Memory at MIT Sept. 22 was that memory is all about the future.Ever since University of California at Berkeley psycho
    October 12, 2022
    SMART researchers develop quick test to determine immunity against Covid-19

    SMART researchers develop quick test to determine immunity against Covid-19

    A team of scientists from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, and Nanyang Technological University, Singapore (NTU Singapore) has developed a quick test kit that can tell if a person has immunity against Covid-19 and its variants, based on the antibodies detected in a blood sample.Unlike ART test kits — which look for the presence
    September 30, 2022
    Microparticles could be used to deliver “self-boosting” vaccines

    Microparticles could be used to deliver “self-boosting” vaccines

    Most vaccines, from measles to Covid-19, require a series of multiple shots before the recipient is considered fully vaccinated. To make that easier to achieve, MIT researchers have developed microparticles that can be tuned to deliver their payload at different time points, which could be used to create “self-boosting” vaccines.In a new study, the researchers describe how these particles degrade
    July 13, 2022
    Advocating for vaccine equity

    Advocating for vaccine equity

    When Digbijay Mahat arrived at MIT in 2017 to begin his postdoctoral studies, he had one very clear goal: to become an expert in cancer research and diagnostics so he could improve health care in Nepal, where he was born. In 2020, when the Covid-19 pandemic laid bare additional discrepancies in resource equity around the world, his goal did not waiver. But it did expand to fill a more immediate ne
    March 18, 2022
    Lessons from teaching about the pandemic in real-time

    Lessons from teaching about the pandemic in real-time

    Just a few months after the Covid-19 pandemic took hold, Alan Grossman was already mulling over an idea for a new class to help people make sense of the virus. As head of MIT’s Department of Biology, he was aware of the key role fundamental research would play in the coming months. From RNA viruses and genomic sequencing to antibodies and vaccines, MIT students and the general public would need re
    May 20, 2021
    Behind Covid-19 vaccine development

    Behind Covid-19 vaccine development

    When starting a vaccine program, scientists generally have anecdotal understanding of the disease they’re aiming to target. When Covid-19 surfaced over a year ago, there were so many unknowns about the fast-moving virus that scientists had to act quickly and rely on new methods and techniques just to even begin understanding the basics of the disease.Scientists at Janssen Research & Development, d
    May 18, 2021
    Contact
    Immunize Oregon
    PO BOX 4391, Portland, Oregon 97208

    United States

    Coordinator@immunizeor.org
    Links
    • Immunize Oregon Website
    Cookies
    Reselect cookie settings
    Community engagement platform by Hivebrite.